InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
40%
T+90 mean return
+5.7%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by BYOM JOHN E, Director. Director active across 2 companies, notably Prestige Consumer Healthcare Inc.. Aggregated, 5 disclosures have been recorded. Activity tracked since 3 August 2021. The latest transaction was disclosed on 6 August 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
2,202 shares0Common Stock, par value $0.01 per shareSEC:0001104659-24-086746:0
2,295 shares0Common Stock, par value $0.01 per shareSEC:0001104659-23-087187:0
2,495 shares0Common Stock, par value $0.01 per shareSEC:0001104659-22-085705:0
2,808 shares0Common Stock, par value $0.01 per shareSEC:0001104659-21-100926:0
2,808 shares0Common Stock, par value $0.01 per shareSEC:0001104659-21-100926
5 of 5 declarations
About BYOM JOHN E
John E. Byom is a Board Member at Prestige Consumer Healthcare Inc. In this role, he participates in the governance of the company and strategic decision-making. With a strong background in the healthcare sector, John E. Byom contributes to the strategic direction of Prestige Consumer Healthcare, fostering innovation and growth. His commitment to corporate responsibility is an asset to the board.
